U.S. Markets open in 7 hrs 51 mins

Akers Biosciences, Inc. (AKR.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
105.000.00 (0.00%)
At close: 3:00PM BST
People also watch
AMS.LAOR.LAGY.LAFN.LAPH.L
Full screen
Previous Close105.00
Open105.00
Bid0.00 x 120000
Ask0.00 x 120000
Day's Range95.00 - 95.00
52 Week Range86.00 - 255.00
Volume287
Avg. Volume2,275
Market Cap9.34M
Beta-0.20
PE Ratio (TTM)-1.94
EPS (TTM)-54
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Akers Biosciences, Inc. :AKR-GB: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017
    Capital Cube13 days ago

    Akers Biosciences, Inc. :AKR-GB: Earnings Analysis: Q1, 2017 By the Numbers : June 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Akers Biosciences, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of GBP 0.54 million, Net Earnings of GBP -1.09 million. Gross margins narrowed from 67.10% to 54.81% compared to the same period last year, operating (EBITDA) margins now -195.04% from -197.89%. Change in operating ... Read more (Read more...)

  • Accesswirelast month

    Investor Network: Akers Biosciences, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 16, 2017 / Akers Biosciences, Inc. (NASDAQ: AKER ) will be discussing their earnings results in their Q1 Earnings Call to be held May 16, 2017 at 9:00 AM Eastern Time. To ...

  • Marketwiredlast month

    Akers Biosciences Announces Q1 2017 Earnings

    Akers Biosciences, Inc. , , a developer of rapid health information technologies, reports its financial results for the first quarter ended March 31, 2017.